Trial Profile
Treatment for acute pyelonephritis caused by extended-spectrum beta-lactamase-producing Escherichia coli: sitafloxacin versus ertapenem following intravenous carbapenem therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2014
Price :
$35
*
At a glance
- Drugs Sitafloxacin (Primary) ; Carbapenems; Ertapenem
- Indications Pyelonephritis
- Focus Therapeutic Use
- 11 Aug 2014 New trial record